Recent insights into organogenesis of the adrenal cortex

Trends in Endocrinology and Metabolism

Volumn 13, Issue 5, 2002, Pages 200-208

  Keegan, Catherine E ^a   Hammer, Gary D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID HORMONE; TRANSCRIPTION FACTOR; CELL RECEPTOR; DAX-1 PROTEIN; DNA BINDING PROTEIN; FUSHI TARAZU PROTEIN; HOMEODOMAIN PROTEIN; NUCLEAR RECEPTOR DAX 1; REPRESSOR PROTEIN; RETINOIC ACID RECEPTOR; STEROIDOGENIC FACTOR 1;

ADRENAL CORTEX; ANIMAL GENETICS; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; GONAD DEVELOPMENT; GROWTH; HUMAN; HUMAN GENETICS; IN VIVO STUDY; MOUSE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; ANIMAL; CONGENITAL ADRENAL HYPERPLASIA; GENE EXPRESSION REGULATION; GENETICS; MALE; NEPHROBLASTOMA; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ADRENAL CORTEX; ADRENAL HYPERPLASIA, CONGENITAL; ANIMALS; DNA-BINDING PROTEINS; FUSHI TARAZU TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; ORGANOGENESIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; WILMS TUMOR;

EID: 0036637499     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(02)00602-1     Document Type: Review

References (101)

1. Okamoto, M. et al. (1998) Implication of ZOG protein (zona glomerulosa-specific protein) in zone development of the adrenal cortex. Endocr. Res. 24, 515-520
2. Mesiano, S. and Jaffe, R.B. (1997) Developmental and functional biology of the primate fetal adrenal cortex. Endocr. Rev. 18, 378-403
3. Nussdorfer, G.G. (1986) Cytophysiology of the adrenal cortex. Int. Rev. Cytol. 98, 1-405
4. Hirokawa, N. and Ishikawa, H. (1974) Electron microscopic observations on postnatal development of the X zone in mouse adrenal cortex. Z. Anat. Entwicklungsgesch. 144, 85-100
5. Donohoe, P.A. et al. (2001) Congenital adrenal hyperplasia. In The Metabolic and Molecular Bases of Inherited Disease (Scriver, C.R. et al., eds), pp. 4077-4116, McGraw-Hill
6. McCabe, E.R.B. (2001) Adrenal hypoplasias and aplasias. In The Metabolic and Molecular Bases of Inherited Disease (Scriver, C.R. et al., eds), pp. 4263-4274, McGraw-Hill
7. Muscatelli, F. et al. (1994) Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372, 672-676
8. Zanaria, E. et al. (1994) An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372, 635-641
9. Goksu, N. et al. (1982) A case of congenital adrenal hypoplasia and review of the literature. Turk. J. Pediatr. 24, 103-108
10. Burke, B.A. et al. (1988) Congenital adrenal hypoplasia and selective absence of pituitary luteinizing hormone: a new autosomal recessive syndrome. Am. J. Med. Genet. 31, 75-97
11. Hastie, N.D. (1993) Wilms' tumor gene and function. Curr. Opin. Genet. Dev. 3, 408-413
12. Pelletier, J. et al. (1991) Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67, 437-447
13. Barbaux, S. et al. (1997) Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat. Genet. 17, 467-470
14. Kreidberg, J.A. et al. (1993) WT-1 is required for early kidney development. Cell 74, 679-691
15. Moore, A.W. et al. (1999) YAC complementation shows a requirement for Wtl in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 126, 1845-1857
16. Vidal, V. and Schedl, A. (2000) Requirement of WT1 for gonad and adrenal development: insights from transgenic animals. Endocr. Res. 26, 1075-1082
17. Cadigan, K.M. and Nusse, R. (1997) Wnt signaling: a common theme in animal development. Genes Dev. 11, 3286-3305
18. Stark, K. et al. (1994) Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372, 679-683
19. Vainio, S.J. and Uusitalo, M.S. (2000) A road to kidney tubules via the Wnt pathway. Pediatr. Nephrol. 15, 151-156
20. Vainio, S. et al. (1999) Female development in mammals is regulated by Wnt-4 signalling. Nature 397, 405-409
21. Jordan, B.K. et al. (2001) Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am. J. Hum. Genet. 68, 1102-1109
22. Lako, M. et al. (1998) Isolation, characterisation and embryonic expression of WNT11, a gene which maps to 11q13.5 and has possible roles in the development of skeleton, kidney and lung. Gene 219, 101-110
23. Morohashi, K. (1997) The ontogenesis of the steroidogenic tissues. Genes Cells 2, 95-106
24. Lala, D.S. et al. (1992) Steroidogenic factor I, a key regulator ofsteroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol. Endocrinol. 6, 1249-1258
25. Hammer, G.D. and Ingraham, H.A. (1999) Steroidogenic factor-1: its role in endocrine organ development and differentiation. Front. Neuroendocrinol. 20, 199-223
26. Hammer, G.D. et al. (1999) Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol. Cell 3, 521-526
27. Monté, D. et al. (1998) Regulation of the human P450scc gene by steroidogenic factor 1 is mediated by CBP/p300. J. Biol. Chem. 273, 4585-4591
28. Ito, M. et al. (1998) Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1. Mol. Endocrinol. 12, 290-301
29. Crawford, P.A. et al. (1998) Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol. Cell. Biol. 18, 2949-2956
30. Ou, Q. et al. (2001) The DEAD box protein DP103 is a regulator of steroidogenic factor-1. Mol. Endocrinol. 15, 69-79
31. Dressel, U. et al. (1999) Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19, 3383-3394
32. Ikeda, Y. et al. (1994) Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol. Endocrinol. 8, 654-662
33. Zhao, L. et al. (2001) Steroidogenic factor 1 (SF-1) is essential for pituitary gonadotrope function. Development 128, 147-154
34. Majdic, G. et al. (2002) Knockout mice lacking steroidogenic factor 1 are a novel genetic model of hypothalamic obesity. Endocrinology 143, 607-614
35. Luo, X. et al. (1994) A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77, 481-490
36. Ikeda, Y. et al. (1995) The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol. Endocrinol. 9, 478-486
37. Achermann, J.C. et al. (1999) A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat. Genet. 22, 125-126
38. Biason-Lauber, A. and Schoenle, E.J. (2000) Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NRSA1/SF-1) and adrenocortical insufficiency. Am. J. Hum. Genet. 67, 1563-1568
39. Correa, R.V. et al. (2001)A microdeletion in the ligand binding domain of steroidogenic factor 1 causing XY sex reversal without adrenal insufficiency. Pediatr. Res. 49, 55A (Abstr.)
40. Achermann, J.C. et al. (2002) Gonadal determination and adrenal development are regulated by the orphan nuclear receptor, steroidogenic factor-1, in a dose-dependent manner. J. Clin. Endocrinol. Metab. 87, 1829-1833
41. Zazopoulos, E. et al. (1997) DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 390, 311-315
42. Lalli, E. et al. (2000) Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA. Mol. Cell. Biol. 20, 4910-4921
43. Yu, R.N. et al. (1998) Role of Ahch in gonadal development and gametogenesis. Nat. Genet. 20, 353-357
44. Bardoni, B. et al. (1994) A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat. Genet. 7, 497-501
45. Swain, A. et al. (1998) Dax-1 antagonizes Sry action in mammalian sex determination. Nature 391, 761-767
46. Merke, D.P. et al. (1999) Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. N. Engl. J. Med. 340,1248-1252
47. Morohashi, K. et al. (2000) Adrenocortical and gonadal differentiation regulated by transcription factors, Ad4BP/SF-1 (NR5A1) and Dax-I (NROB1). Endocr. Res. 26, 953 (abstr.)
48. Zhang, H. et al. (2000) DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J. Biol. Chem. 275, 39855-39859
49. Holter, E. et al. (2002) Inhibition of androgen receptor (ar) function by the reproductive orphan nuclear receptor DAX-1. Mol. Endocrinol. 16, 515-528
50. Ikeda, Y. et al. (1996) Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol. Endocrinol. 10, 1261-1272
51. Yu, R.N. et al. (1998) The murine Dax-1 promoter is stimulated by SF-1 (steroidogenic factor-1) and inhibited by COUP-TF (chicken ovalbumin upstream promoter-transcription factor) via a composite nuclear receptor-regulatory element. Mol. Endocrinol. 12, 1010-1022
52. Ito, M. et al. (1997) DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell. Biol. 17, 1476-1483
53. Hanley, N.A. et al. (2001) Expression profiles of SF1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation. Mol. Endocrinol. 15, 57-68
54. Babu, P.S. et al. (2002) Dax-1 inhibits SF-1-mediated steroidogenesis in acute stress responses in vivo. Endocrinology 143, 655-673
55. Nachtigal, M.W. et al. (1998) Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 93, 445-454
56. Gummow, B.M. et al. Convergence of Wnt signaling and SF-1 on transcription of the rat inkibin-α gene. Endocrine. Soc. Annu. Meeting Abstr. (in press)
57. Howard-Miller, E. (1928) A transitory zone in the adrenal cortex which shows age and sex relationships. Am. J. Anat. 40, 251-293
58. Holmes, P.V. and Dickson, A.D. (1971) X-zone degeneration in the adrenal glands of adult and immature female mice. J. Anat. 108, 159-168
59. Carsia, R.V. et al. (2000) The role ofcaspase-2 and -11 in adrenocortical modeling. Endocrine Soc. Annu. Meeting Abstr. 82, 212 (Abstr.)
60. Zajicek, G. et al. (1986) The streaming adrenal cortex: direct evidence of centripetal migration of adrenocytes by estimation of cell turnover rate. J. Endocrinol. 111, 477-482
61. Greep, R.O. and Deane, H.W. (1949) Histological, cytochemical and physiological observations on the regeneration of the rat's adrenal gland following enucleation. Endocrinology 45, 42-56
62. Halder, S.K. et al. (1998) Cloning of a membrane-spanning protein with epidermal growth factor-like repeat motifs from adrenal glomerulosa cells. Endocrinology 139, 3316-3328
63. Mitani, F. et al. (1999) Development of functional zonation in the rat adrenal cortex. Endocrinology 140, 3342-3353
64. Morley, S.D. et al. (1996) Variegated expression of a mouse steroid 21-hydroxylase/β-galactosidase transgene suggests centripetal migration of adrenocortical cells. Mol. Endocrinol. 10, 585-598
65. Hochgeschwender, U. et al. (2001) Adrenal gland development in Pomc-null mutant mice. Endocrine Soc. Annu. Meeting Abstr. 83, 138 (Abstr.)
66. Krude, H. and Gruters, A. (2000) Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome. Trends Endocrinol. Metab. 11, 15-22
67. Yaswen, L. et al. (1999) Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 5, 1066-1070
68. Dallman, M.F. et al. (1976) Compensatory adrenal growth: a neurally mediated reflex. Am. J. Physiol. 231, 408-414
69. Dallman, M.F. et al. (1980) Adrenocorticotropin inhibits compensatory adrenal growth after unilateral adrenalectomy. Endocrinology 107, 1397-1404
70. Lowry, P.J. et al. (1983) Pro-γ-melanocyte-stimulating hormone cleavage in adrenal gland undergoing compensatory growth. Nature 306, 70-73
71. Estivariz, F.E. et al. (1982) Stimulation of adrenal mitogenesis by N-terminal proopiocortin peptides. Nature 297, 419-422
72. Bicknell, A.B. et al. (2001) Characterization of a serine protease that cleaves pro-γ-melanotropin at the adrenal to stimulate growth. Cell 105, 903-912
73. Dallman, M.F. (1984) Control of adrenocortical growth in vivo. Endocr. Res. 10, 213-242
74. Matzuk, M.M. et al. (1994) Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 91, 8817-8821
75. Zhang, P. et al. (1997) Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387, 151-158
76. Schofield, P.N. et al. (1995) Expression of a high molecular weight form of insulin-like growth factor II in a Beckwith-Wiedemann syndrome associated adrenocortical adenoma. Cancer Lett. 94, 71-77
77. Eggenschwiler, J. et al. (1997) Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev. 11, 3128-3142
78. Wagner, J. et al. (1994) High frequency of germline p53 mutations in childhood adrenocortical cancer. J. Natl. Cancer Inst. 86, 1707-1710
79. Kirschner, L.S. et al. (2000) Mutations of the gene encoding the protein kinaseA type I-α regulatory subunit in patients with the carney complex. Nat. Genet. 26, 89-92
80. Weinstein, L.S. et al. (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med. 325, 1688-1695
81. Bamforth, S.D. et al. (2001) Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat. Genet. 29, 469-474
82. Shire, J.G. and Spickett, S.G. (1968) A strain difference in the time and mode of regression of the adrenal X zone in female mice. Gen. Comp. Endocrinol. 11, 355-365
83. Shire, J.G. (1969) A strain difference in the adrenal zona glomerulosa determined by one gene-locus. Endocrinology 85, 415-422
84. Beamer, W.G. et al. (1994) Adrenocortical dysplasia: a mouse model system for adrenocortical insufficiency. J. Endocrinol. 141, 33-43
85. Chen, F. et al. (1999)Lbx2, a novel murine homeobox gene related to the Drosophila ladybird genes is expressed in the developing urogenital system, eye and brain. Mech. Dev. 84, 181-184
86. Kume, T. et al. (2000) Minimal phenotype of mice homozygous for a null mutation in the forkhead/winged helix gene, Mf2. Mol. Cell. Biol. 20, 1419-1425
87. Lahoud, M.H. et al. (2001) Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res. 11, 1327-1334
88. Duprez, D. et al. (1999) Expression of Frzb-1 during chick development. Mech. Dev. 89, 179-183
89. Dewing, P. et al. (2000) Midkine is expressed early in rat fetal adrenal development. Mol. Genet. Metab. 71, 616-622
90. Miller, W.L. et al. (1997) The regulation of 17,20 lyase activity. Steroids 62, 133-142
91. Keeney, D.S. et al. (1995) Developmentally regulated expression of adrenal 17α-hydroxylase cytochrome P450 in the mouse embryo. Endocrinology 136, 4872-4879
92. Arlt, W. et al. (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. N. Engl. J. Med. 341, 1013-1020
93. Hunt, P.J. et al. (2000) Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J. Clin. Endocrinol. Metab. 85, 4650-4656
94. Pelletier, J. et al. (1991) WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumor. Nature 353, 431-434
95. Clark, A.J. et al. (1993) Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 341, 461-462
96. Tsigos, C. et al. (1993) Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene. J. Clin. Invest. 92, 2458-2461
97. Caron, K.M. et al. (1997) Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc. Natl. Acad. Sci. U. S. A. 94, 11540-11545
98. Tajima, T. et al. (2001) Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J. Clin. Endocrinol. Metab. 86, 3820-3825
99. Tullio-Pelet, A. et al. (2000) Mutant WD-repeat protein in triple-A syndrome. Nat. Genet. 26, 332-335
100. Handschug, K. et al. (2001) Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum. Mol. Genet. 10, 283-290
101. Carsia, R.V. et al. (2000) The sphingomyelin pathway regulates adrenocortical apoptosis and modeling. Endocrine Soc. Annu. Meeting Abstr. 82, 212 (Abstr.)